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Reducing the dependency of fishfeed for marine ingredients and species diversification 32 
are both considered crucial factors for the sustainable development of aquaculture. The 33 
substitution of fish oil (FO) by vegetable oils (VO) in aquafeeds is an economically 34 
feasible solution. However, such substitution may compromise the fish flesh content of 35 
essential n-3 long chain polyunsaturated fatty acids (n-3 LC-PUFA) and, therefore, its 36 
nutritional value for human consumption. Likewise, there is a wide range of strategies to 37 
select new target species for sector diversification, among which, the capacity to 38 
biosynthesize n-3 LC-PUFA from their C18 precursors abundant in VO might be 39 
considered as a fair preliminary strategy. Therefore, the aim of the present study was to 40 
analyze the metabolic fate of [1-14C] labeled 18:2n-6, 18:3n-3, 20:5n-3 and 22:6n-3 in 41 
isolated hepatocytes and enterocytes from wild individuals of three fish species with 42 
different trophic level: the marine herbivorous salema (Sarpa salpa), the strict 43 
carnivorous sand sole (Pegusa lascaris) and the omnivorous thicklip grey mullet (Chelon 44 
labrosus). These species were selected for their phylogenetic proximity to consolidated 45 
farmed species such as gilthead seabream (Sparus aurata), senegalese sole (Solea 46 
senegalensis), and golden grey mullet (Liza aurata), respectively. The study also assessed 47 
the molecular cloning, functional characterization and tissue distribution of the fatty acyl 48 
elongase (Elovl) gene, elovl5, involved in the biosynthetic metabolism of n-3 LC-PUFA. 49 
The three species were able to biosynthesize docosahexaenoic acid (22:6n-3). S. salpa 50 
seems to have similar biosynthetic capacity than S. aurata, with a fatty acyl desaturase 2 51 
(Fads2), with 6, 8 and 5 activities. P. lascaris showed a wider Fads2 activity 52 
repertory than S. senegalensis, including 4 and residual 6/5 activities. In C. labrosus, 53 
both 8 and 5 activities but not the 6 described for L. aurata were detected in the 54 
incubated cells. Elongation from C18 and C20 precursors to C20 and C22 products occurred 55 
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in hepatocytes and enterocytes as well as in the functional characterization of Elovl5 by 56 
heterologous expression in yeast. Elovl5 showed a species specific expression pattern, 57 
with the highest rates observed in the liver, gut and brain in S. salpa and P. lascaris, and 58 
in the brain for C. labrosus. In summary, the LC-PUFA biosynthesis capacity from S. 59 
salpa, P. lascaris and C. labrosus greatly resembled that of their phylogenetic closer 60 
species. The three studied species could be further explored as candidates for the 61 
aquaculture diversification from their potential ability to biosynthesize LC-PUFA. 62 
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1. Introduction 66 
The annual per capita consumption of fish has risen up to 20.2 Kg in 2015, partly due 67 
to its contribution to the population needs for high-quality proteins, lipids and 68 
micronutrients (FAO, 2018). Lipids, and their main components, fatty acids (FA), are 69 
along with proteins, the largest organic components of fish. C18 polyunsaturated fatty 70 
acids (PUFA) such as 18:2n-6 and 18:3n-3, are considered essential nutrients for 71 
vertebrates because they cannot be synthesized de novo. Additionally, they are metabolic 72 
precursors of the physiologically important long-chain (C20-24) PUFA (LC-PUFA) 73 
including arachidonic (20:4n-6, ARA), eicosapentaenoic (20:5n-3, EPA), and 74 
docosahexaenoic (22:6n-3, DHA) acids (Tocher, 2015). LC-PUFA are involved in key 75 
roles including cell membrane structure, transcription, regulation and cellular signalling 76 
(Lee et al., 2016; Tocher, 2015; Zárate et al., 2017). Particularly, the n-3 LC-PUFA 20:5n-77 
3 and 22:6n-3 have been seen to prevent several human inflammatory and 78 
neurodegenerative illnesses (Lee et al., 2016; Zárate et al., 2017). 79 
Fish, including farmed species, are the primary source of n-3 LC-PUFA for humans 80 
(Bell and Tocher, 2009). However, the fluctuating availability of marine ingredients used 81 
in aquafeed formulation, namely fish oil (FO) and fishmeal, their sustained price increase, 82 
the increment of global aquaculture production and the necessity to search for more 83 
sustainable alternatives to feed carnivorous species have resulted in a pressing need for 84 
their partial replacement by ingredients of terrestrial origin such as vegetable oils (VO). 85 
This practice reduces the n-3 LC-PUFA content in fish muscle (Pérez et al., 2014; Tocher, 86 
2015) and therefore, its nutritional value to consumers. Recently, the use of oils from 87 
transgenic plants and the inclusion of micro and macroalgae-origin products rich in n-3 88 
LC-PUFA have been proposed as possible novel alternatives to marine sources (Ruyter 89 
et al., 2019; Sprague et al., 2016; Tocher et al., 2019). Moreover, farming of fish species 90 
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with high capacity to biosynthesize LC-PUFA from their C18 precursors abundant in VO 91 
may also be considered as a valuable sustainable strategy for the aquaculture industry 92 
(Garrido et al., 2019). Therefore, it is essential to understand the LC-PUFA metabolism 93 
of potential candidate species for the diversification of aquaculture in order to select fish 94 
with high capacity to utilize dietary VO while maintaining proper growth and 95 
development, as well as its nutritional quality in terms of n-3 LC-PUFA content.  96 
Liver is the main organ involved in lipid metabolism while gut have an important role 97 
in both uptake and LC-PUFA biosynthesis. In this sense, the incorporation and 98 
bioconversion of radiolabeled FA in enterocytes and hepatocytes from fish species have 99 
been demonstrated as an adequate tool to elucidate their LC-PUFA biosynthesis 100 
capabilities (Díaz-López et al., 2010; Garrido et al., 2020; Morais et al., 2015; Mourente 101 
and Tocher, 1993a, 1993b, 1994; Rodríguez et al., 2002; Tocher and Ghioni, 1999).  102 
LC-PUFA biosynthesis in vertebrates including fish, is mediated by two types of 103 
enzymes (Monroig et al., 2018). On the one hand, the fatty acyl elongase (Elovl) proteins 104 
catalyze the condensation reaction of the fatty acid elongation pathway resulting in the 105 
extension of the fatty acyl chain in two carbons. Thus, enzymes such as Elovl5, Elovl2 106 
and Elovl4 are being extensively studied in fish (Castro et al., 2016; Garlito et al., 2019; 107 
Monroig et al., 2018). On the other hand, fatty acyl desaturases (Fads) enzymes enter a 108 
double bond to PUFA substrates in between an existing one and the carbon of the 109 
carboxylic group. The Greek letter (Δ) is used to denote the position of the double bond 110 
created by Fads in the hydrocarbon chain. Unlike mammalian FADS2 that typically have 111 
6/8 activity (Castro et al., 2016), teleost Fads2 show high interspecific variability in 112 
their desaturase capacity. Thus, along with the 6/8 activity (Monroig et al., 2011a), 113 
Fads2 with 4 and 5, as well as bifunctional 6/5 desaturases have been reported 114 
(Castro et al., 2016; Garrido et al., 2020; Monroig et al., 2011a, 2018). The production of 115 
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20:4n-6 and 20:5n-3 from 18:2n-6 or 18:3n-3, respectively, may be obtained by a 6 116 
desaturation activity towards C18 substrates followed by an elongation step and a final 5 117 
desaturation (Fig. 1). Alternatively, a 8 desaturation over C20 intermediates may be also 118 
involved in the production of 20:4n-6 and 20:5n-3 from C18 precursors (Monroig et al., 119 
2011a). The biosynthesis of 22:6n-3 from 20:5n-3 can be mediated via the Sprecher 120 
pathway (Sprecher, 2000), which requires two consecutive elongation steps, a 6 121 
desaturation, and a final peroxisomal β-oxidation or through an alternative and more 122 
direct route with the action of a 4 desaturase (Li et al., 2010; Oboh et al., 2017) (Fig. 1).  123 
The biosynthetic ability of each species to biosynthesize LC-PUFA was believed until 124 
very recently to depend on the species’ habitat (freshwater vs marine), with marine 125 
species having limited capacity to convert C18 PUFA to LC-PUFA, and 126 
freshwater/diadromous fish having retained the ability to elongate and desaturate C18 127 
precursors (Garrido et al., 2019; Monroig et al., 2018). Such generalization was 128 
questioned when the marine herbivore, Siganus canaliculatus, was reported to have a 4 129 
Fads2 and a bifunctional 5/6 Fads2 (Li et al., 2010). Further studies demonstrated the 130 
presence of 4 Fads2 in teleost species from a variety of habitats and trophic levels 131 
(Fonseca-Madrigal et al., 2014; Garrido et al., 2019; Kuah et al., 2015; Morais et al., 132 
2012, 2015; Oboh et al., 2017). Thus, other factors such as phylogeny have been recently 133 
pointed out to influence the LC-PUFA biosynthetic capacity of teleosts (Castro et al., 134 
2016; Garrido et al., 2019; Monroig et al., 2018). In teleosts, Elovl5 and Elovl2 share a 135 
common evolutionary origin (Monroig et al., 2016), and consequently, both of them have 136 
preference for C18 and C20 PUFA substrates although Elovl5 has also been reported to 137 
present some affinity towards C22 PUFA (Monroig et al., 2012).  138 
In order to explore the potentiality of a wider range of species for the diversification 139 
of finfish aquaculture, based on their n-3 LC-PUFA biosynthesis capabilities, three fish 140 
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species with different trophic levels were selected in the present study: the salema Sarpa 141 
salpa (Linnaeus, 1758), a marine herbivorous of the Sparidae family with trophic affinity 142 
with S. canaliculatus; the sand sole Pegusa lascaris (Risso, 1810), a strict carnivorous 143 
member of the Soleidae family that is phylogenetically close to Solea senegalensis; and 144 
the thicklip grey mullet Chelon labrosus (Risso, 1827), a species from the Mugilidae 145 
family closely related to Liza aurata with high adaptability to different feeding habits. 146 
Molecular cloning, functional characterization and tissue distribution of 6 and 8 147 
desaturase have been already described by our group in S. salpa and C. labrosus, as well 148 
as 4 desaturase in P. lascaris (Garrido et al., 2019). However, their LC-PUFA 149 
metabolism capacities were not completely characterized. To this aim, isolated 150 
enterocytes and hepatocytes were incubated with different PUFA substrates, in order to 151 
compare their uptake affinities and the ability of Fads2 and Elovl to desaturate and 152 
elongate C18 and C20 radiolabeled FA precursors. Furthermore, the molecular cloning, 153 
functional characterization and tissue distribution of elovl5 elongases were also 154 
elucidated. The results of the present study are discussed within the context of fish 155 
nutrition and their applicability to the diversification of aquaculture with species able to 156 
efficiently utilize ingredients alternative to FO. 157 
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2. Material and methods 158 
2.1 Experimental animals and sampling 159 
All experimental procedures were approved by the Ethical Committee at the 160 
University of La Laguna and were in accordance with the EU Directive 2010/63/EU 161 
regarding the protection and humane use of animals for scientific purpose (European 162 
Parliament and Council of the European Union, 2010). 163 
Wild specimens of S. salpa (87.4 ± 14.4 g; n=5) and C. labrosus (12.5 ± 9.1 g; n=6) 164 
were captured by professional artisanal fishermen in Tenerife (Spain), while P. lascaris 165 
(111.2 ± 25.5 g; n=3) were captured off the coast of Huelva (Spain). Fish were 166 
subsequently transported to the laboratory for sacrifice and subsequent sampling. 167 
Samples of muscle, liver, heart, foregut, brain and gill were collected for molecular 168 
cloning, functional characterization and tissue distribution. Tissues were kept in 169 
RNAlater (Qiagen Iberia SL, Madrid, Spain) the first 24 h at 4oC and then stored at -20oC 170 
until analysis. In addition, the remaining foregut and liver were rapidly taken for the 171 
isolation of enterocytes and hepatocytes, respectively. The isolated cells were used for 172 
incubation and final extraction of the total lipid (TL) required to either assess the FA 173 
composition of control cells or to evaluate the incorporation of radioactivity into TL and 174 
the bioconversion rates of FA in the radiolabeled [1-14C] incubated cells. Furthermore, 175 
muscle samples were also used for lipid and FA composition determination. The whole 176 
process was developed under an ice-cold environment to prevent sample degradation. 177 
2.2 Isolation of enterocytes and hepatocytes and incubation with radiolabeled [1-178 
14C] fatty acids  179 
Enterocytes and hepatocytes were obtained as described by Rodrı́guez et al. (2002). 180 
Organs from two or more fish were pooled in the case of P. lascaris and C. labrosus due 181 
to the small size of the animals. Before the beginning of the experiments, the foregut was 182 
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cleaned of food and feces and the liver perfused through the hepatic portal vein with a 183 
solution of marine Ringer containing 116 mM NaCl, 6 mM KCl, 1 mM CaCl2, 1 mM 184 
MgSO4, 10 mM NaHCO3, 1 mM NaH2PO4, 10 mM K2SO4 and 10 mM HEPES (pH 7.4). 185 
Tissues were minced in Hanks balanced salt solution (HBSS) with NaCl 1.75% (w/v) 186 
(HBSS/NaCl), 9.69 mM HEPES, 1.73 mM NaHCO3, and collagenase (10 mg/mL) and 187 
incubated with HBSS/collagenase in agitation for 40 min at 20ºC. The resultant cell 188 
suspensions were filtered through a 100 µm nylon mesh with HBSS including 1% (w/v) 189 
fatty acid free bovine serum albumin (FAF-BSA). Cells were collected by centrifugation 190 
(Beckman Coulter Allegra 25R, Indianapolis, USA) at 716 g for 10 min, washed with 191 
HBSS and re-centrifuged for 7 min. The isolated cells were then re-suspended in cold 192 
M199 medium with NaCl and a sample was taken to assess the viability of cells (over 193 
90% in all cases) by using the trypan blue exclusion test. 194 
Immediately after isolation, 6 mL of each cell preparation were incubated in sterile 195 
plastic flasks for 3 h with 40 µL (0.20 µCi) of radiolabeled [1-14C] PUFA: 18:2n-6, 18:3n-196 
3, 20:5n-3 or 22:6n-3, with specific activities of 124.3, 114.8, 122.1 and 122.1 dpm pmol-197 
1, respectively. A control incubation of 2 mL of each cell type suspension without the 198 
addition of radiolabeled FA was also performed under the same experimental conditions 199 
for the determination of FA profiles. Samples were stored at -80°C until analysis. 200 
2.3 Lipid extraction and protein determination 201 
The TL content of isolated cells (enterocytes and hepatocytes) was extracted after 202 
incubation with small modifications of the Folch method (Folch et al., 1957) as described 203 
by Christie and Han (2010). Briefly, either incubated control or radioactive cell 204 
preparations, were transferred into test tubes, centrifuged at 716 g for 5 min and the 205 
resultant pellets re-suspended in 4 mL of HBSS and re-centrifuged. Pellets were dissolved 206 
in 2 mL of 0.88% KCl (w/v), and 8 mL of chloroform/methanol (2:1, v/v) containing 207 
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0.01% (w/v) butylated hydroxytoluene (BHT) as antioxidant. After vigorous shaking, 208 
samples were re-centrifuged at 716 g for 5 min, the organic solvent collected, filtered, 209 
and evaporated under a stream of nitrogen. The TL content was determined 210 
gravimetrically, re-suspended in chloroform/methanol (2:1, v/v) with 0.01% (w/v) BHT 211 
and stored at -20ºC under an atmosphere of nitrogen until further analysis. For the lipid 212 
extraction of muscle samples, the same procedure as described above was performed, but 213 
tissue was previously homogenized in chloroform/methanol (2:1, v/v) using a Virtis rotor 214 
homogenizer (Virtishear, Virtis, Gardiner, New York).  215 
Total protein content of incubated enterocytes and hepatocytes was determined in 100 216 
µL-aliquots of cell suspensions, according to Lowry et al. (1951) using FAF-BSA as 217 
standard. 218 
2.4 FA composition of non-radioactive samples 219 
In order to assess the baseline FA composition of liver and gut epithelial cells from the 220 
three species, a smaller fraction (2 mL) of isolated enterocytes and hepatocytes 221 
suspensions that had been also incubated without [1-14C] PUFA, were finally analyzed. 222 
Up to 1 mg of TL extracted from these control cell suspensions and from muscle samples 223 
were subjected to acid-catalyzed transmethylation to obtain fatty acid methyl esters 224 
(FAME). Resultant FAME were purified by thin-layer chromatography (Macherey-225 
Nagel, Düren, Germany), separated and quantified using a TRACE-GC Ultra gas 226 
chromatograph (Thermo Scientific, Milan, Italy) equipped with an on-column injection, 227 
a flame ionization detector (FID) and a fused silica capillary column Supelcowax® 10 228 
(30 m x 0.32 mm ID, df 0.25 μm) (Supelco Inc., Bellefonte, USA). Helium was used as 229 
the carrier gas at 1.5 mL/min constant flow, and temperature programming was from 50 230 
to 150ºC at a rate of 40ºC/min, then from 150oC to 200ºC at 2ºC/min, to 214ºC at 1ºC/min 231 
and, finally, to 230ºC at 40ºC/min, which was maintained for 3 min. Individual FAME 232 
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were identified by reference to authentic standards and further confirmation of FAME 233 
identity was carried out by GC-MS (DSQ II, Thermo Scientific) when necessary. The 234 
results are expressed as percentage of total FA.  235 
Muscle FA composition of the three studied species is shown in the supplementary 236 
data table. 237 
2.5 Metabolic fate of [1-14C] PUFA. Incorporation of radioactivity into TL and 238 
bioconversion of radiolabeled FA 239 
A 100 µg aliquot of TL from cells incubated with each radiolabeled FA (18:2n-6, 240 
18:3n-3, 20:5n-3 or 22:6n-3) was used to determine the radioactivity incorporated by 241 
means of a liquid scintillation β-counter (TRI-CARB 4810TR, Perkin Elmer, Singapore). 242 
Results obtained in dpm were related to the specific activity of each fatty acid and to the 243 
cells TL and protein contents, and expressed as pmol mg prot-1 h-1. 244 
Desaturation-elongation capacities of isolated enterocytes and hepatocytes from the 245 
three fish species incubated with [1-14C] PUFA (18:2n-6, 18:3n-3 and 20:5n-3) were 246 
determined using aliquots of up to 1 mg of the TL extract. Samples were subjected to 247 
acid-catalyzed transmethylation and the resultant FAME were then purified by 248 
argentation thin layer chromatography (AgNO3-TLC) using TLC plates previously 249 
impregnated with 2 g silver nitrate in 20 mL acetonitrile and activated at 110ºC for 30 250 
min. A known standard composed by a mixture of radiolabeled FA was also developed 251 
in the same plates for the identification of each band. TLC plates were fully developed in 252 
toluene/acetonitrile (95:5, v/v) to separate the bands of [1-14C] FA (Wilson and Sargent, 253 
1992). Then, they were placed in closed exposure cassettes in contact with a radioactive-254 
sensitive phosphorous screen (Exposure Cassette-K, BioRad, Madrid, Spain) for two 255 
weeks. Screens were scanned with an image acquisition system (Molecular Imager Fx, 256 
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BioRad), and bands were identified and quantified in percentage of area using Quantity 257 
One 4.5.2. (BioRad) image software.  258 
2.6 Molecular cloning of elovl5 cDNAs 259 
Total RNA was extracted from each tissue (muscle, heart, liver, gut, brain and gill) 260 
and species using TRI Reagent (Sigma-Aldrich, Dorset, UK) following the 261 
manufacturer’s instructions and using a bead tissue disruptor (Bio Spec, Bartlesville, 262 
Oklahoma, USA). Next, cDNA was synthesized from 2 μg of total RNA (mixture from 263 
brain and liver; 1:1) for each species using a High Capacity cDNA Reverse Transcription 264 
Kit (Applied Biosystems, California, USA) for molecular cloning. Subsequently, the first 265 
fragment of elovl5 genes for each species were obtained by polymerase chain reaction 266 
(PCR) using the cDNA as template together with degenerated primers (Table 1) and 267 
GoTaq® Green Master Mix (Promega, Southampton, UK). The degenerated primers for 268 
elovl5 were designed on conserved regions from sequences obtained from NCBI blastn 269 
tool (http://www.ncbi.nlm.nih.gov/) of several teleosts including S. canaliculatus 270 
(GU597350.1), Epinephelus coioides (KF006241.1), Rachycentron canadum 271 
(FJ440239.1), S. senegalensis (JN793448.1), Chirostoma estor (KJ417837.1), S. aurata 272 
(AY660879.1) and Salmo salar (NM_001123567.2). The alignment of elovl5 sequences 273 
was carried out with BioEdit v7.0.9 (Tom Hall, Department of Microbiology, North 274 
Carolina State University, North Carolina, USA). The amplification of the first fragments 275 
by PCR were performed by an initial denaturing step at 95°C for 2 min, followed by the 276 
PCR conditions shown in Table 2 for each primer set, followed by a final extension at 277 
72°C for 5 min. The amplified PCR fragments were purified on agarose gels using 278 
IllustraTM GFXTM PCR DNA and Gel Band Purification kit (GE Healthcare Life Sciences, 279 
Buckinghamshire, UK) and cloned into pGEM-T Easy vector (Promega) and sequenced 280 
(GATC Biotech, Konstanz, Germany). Then, the obtained sequences were used for 281 
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designing specific primers that allowed obtaining the 5’ and 3’ regions by Rapid 282 
Amplification of cDNA Ends (RACE). The cDNA for RACE was prepared by 283 
FirstChoice® RLM-RACE kit (Ambion, Applied Biosystems, Warrington, UK) 284 
following manufacturer’s recommendations. All RACE PCR conditions and primers used 285 
are also reported in Tables 1 and 2. After the nested PCR using the first PCR product as 286 
a template, we successfully amplified each cDNA ends fragment. All RACE fragments 287 
were sequenced as described above and assembled with the corresponding first-fragments 288 
to obtain putative full-length cDNA. 289 
2.7 Sequence and phylogenetic analyses 290 
The deduced amino acid (aa) sequences of putative Elovl5 proteins isolated from S. 291 
salpa, P. lascaris and C. labrosus with a variety of functionally characterized Elovl2, 292 
Elovl4 and Elovl5 from vertebrates (human and fish) retrieved from NCBI were aligned 293 
using MAFFT (https://mafft.cbrc.jp/alignment/software/) Ver. 7.388 with the E-INS-i 294 
strategy (Katoh et al., 2019). All columns containing gaps in the obtained alignment were 295 
removed by trimAl (Capella-Gutiérrez et al., 2009). The cleaned alignment was subjected 296 
to a maximum likelihood phylogenetic analysis using RAxML with 1000 rapid bootstrap 297 
replicates. The best-fit evolutionary model was selected to LG+G+I for both genes by 298 
ModelTest-NG (Darriba et al., 2020). The resultant RAxML tree was visualized using 299 
Interactive Tree of Life v3 (Letunic and Bork, 2016). 300 
2.8 Functional characterization 301 
The open reading frames (ORF) of elovl5 were amplified from S. salpa, P. lascaris 302 
and C. labrosus from liver cDNA by a nested PCR approach. All primers and PCR 303 
conditions are described in Tables 1 and 2. First-round of PCR used primer pairs designed 304 
for each species in the 5’ and 3’ untranslated regions (UTR) for forward and reverse 305 
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primers, respectively. Second round of PCR was run using the first-round PCR products 306 
as templates and primers containing restriction sites (underlined in Table 1) for 307 
subsequent ligation into the yeast expression vector pYES2 (Thermo Fisher Scientific, 308 
Hemel Hempstead, UK). In the case of P. lascaris, both first and second round PCR were 309 
performed with the high fidelity Pfu DNA polymerase (Promega), whereas for S. salpa 310 
and C. labrosus elovl5 the PfuUltra II Fusion HS DNA Polymerase (Agilent, Santa Clara, 311 
California, USA) was used. Subsequently, the PCR products were purified, digested with 312 
the corresponding restriction enzymes (New England BioLabs, Hitchin, UK) and ligated 313 
into a similarly restricted pYES2. The plasmids containing pYES2-elovl5 from each 314 
species were purified (GenElute™ Plasmid Miniprep Kit, Sigma) and sequenced before 315 
being transformed into yeast Saccharomyces cerevisiae competent cells InvSc1 (Thermo 316 
Fisher Scientific). Transformation and selection of yeast culture were performed as 317 
described by Garrido et al. (2019). One single yeast colony transformed with pYES2-318 
elovl5 for each species was used for functional assays. The transgenic yeasts were grown 319 
in the presence of one of the potential FA substrates for elongases, namely 18:2n-6, 18:3n-320 
3, 18:3n-6, 18:4n-3, 20:4n-6, 20:5n-3, 22:4n-6 and 22:5n-3. The FA substrates were 321 
added to the yeast cultures at final concentrations of 0.5 mM (C18), 0.75 mM (C20) and 322 
1.0 mM (C22) as uptake efficiency decreases with increasing chain length (Kabeya et al., 323 
2018). In addition, yeasts transformed with empty pYES2 were also grown in the presence 324 
of each substrate as control treatments. After 2 days of culture at 30°C, yeasts were 325 
harvested, washed, and TL extracted by homogenization in chloroform/methanol (2:1, 326 
v/v) containing 0.01% (w/v) BHT as antioxidant. 327 
2.9 Fatty acid analysis of yeast 328 
FAME were determined from the TL extracted from yeast according to Hastings et al. 329 
(2001). FAME were separated and quantified using a Fisons GC-8160 (Thermo Fisher 330 
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Scientific) gas chromatograph equipped with a 60 m x 0.32 mm i.d. x 0.25 μm ZB-wax 331 
column (Phenomenex, Macclesfield, UK) and flame ionization detector. The elongation 332 
conversion efficiencies from exogenously added PUFA substrates were calculated by the 333 
proportion of substrate FA converted to elongated products as [product area / (product 334 
area + substrate area)] × 100. 335 
2.10 Tissue expression of elovl5 336 
Expression of the elovl5 gene was determined by quantitative real-time PCR (qPCR) 337 
in muscle, heart, liver, gut, brain and gill, being the number of replicates n=4 in S. salpa 338 
and P. lascaris, and n=3 in C. labrosus. Elongation factor-1α (ef1α) and β-actin (actb) 339 
and 18S were tested as potential reference genes for normalization of elovl5 expression, 340 
with ef1α and actb being selected for that purpose since they were the most stable genes 341 
according to geNorm (M stability value = 0.165; Vandesompele et al., 2002). Total RNA 342 
was extracted and 2 μg of each sample were reverse transcribed into cDNA as described 343 
above. In the interest of assessing the efficiency of the primer pairs, serial dilutions of 344 
pooled cDNA were carried out for each species. All qPCR were performed by a Biometra 345 
TOptical Thermocycler (Analytik Jena, Jena, Germany) in 96-well plates in duplicates at 346 
total volume of 20 μL containing 10 μL of Luminaris Color HiGreen qPCR Master Mix 347 
(Thermo Fisher Scientific), 1 μL of each primer (10 μM), 2 μL or 5 μL of cDNA (1/20 348 
dilutions) for reference and target genes, respectively, as well as 6 or 3 μL of molecular 349 
biology grade water. Besides, negative controls (NTC, no template control), containing 350 
molecular biology grade water instead of cDNA, were also run in each plate. The primer 351 
sequences and qPCR conditions are detailed in Tables 1 and 2, respectively. The relative 352 
expression of elovl5 among tissues in each species was calculated as arbitrary units after 353 
normalization dividing by the geometric mean of the expression level of the reference 354 
genes elf1α and actb. One arbitrary unit is defined as the ratio between the expression 355 
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level of elovl5 and the lowest expression level for this gene. After each qPCR analysis, a 356 
melting curve with 1°C increments during 6 s from 60 to 95°C was performed, in order 357 
to check the presence of a single product in each reaction. 358 
2.11 Statistical analysis 359 
Results for TL, FA composition, incorporation of radioactivity into TL, and 360 
bioconversions of enterocytes and hepatocytes incubated with [1-14C] FA substrates are 361 
presented as mean ± SD (n=5 for S. salpa, except for [1-14C] 22:6n-3 where n=4; n=6 for 362 
C. labrosus and n=3 for P. lascaris). Tissue expression is presented as log 10 mean 363 
normalized ratios ± standard error (N). P values of less than 0.05 were considered 364 
significantly different for all statistical test applied. Normal distribution of the data and 365 
homogeneity of the variances were verified with the one-sample Shapiro-Wilk test and 366 
the Levene test, respectively (Zar, 1999).  367 
Statistical differences in the incorporation of radioactivity into TL in enterocytes and 368 
hepatocytes incubated with [1-14C]FA substrates (18:2n-6, 18:3n-3, 20:5n-3 and 22:6n-369 
3), the bioconversions of [1-14C]FA substrates in enterocytes and hepatocytes (18:2n-6, 370 
18:3n-3 and 20:5n-3) as well as tissue expression were tested by one-way ANOVA 371 
followed by a Tukey HSD multiple comparison test (Zar, 1999) for each cell type and 372 
species. When homocedasticity was not achieved, data were transformed using logarithm 373 
or arcsine square root. If transformations did not succeed, Welch test was performed, 374 
followed by T3 Dunnet. Kruskall-Wallis non-parametric test was applied in the case of 375 
no normal distribution followed by pair-wise comparisons Mann-Whitney test with 376 
Bonferroni correction. When one group was missing, the remaining two groups were 377 
analyzed by t-student or Mann-Whitney tests for no normal data. All statistical analyses 378 




3. Results  381 
3.1 Lipid content and fatty acid composition of control cells, and incorporation of 382 
radioactivity into total lipids of cells incubated with [1-14C] radiolabeled FA 383 
Table 3 shows the FA composition of enterocytes and hepatocytes from the three fish 384 
species studied. Saturates, mainly represented by 16:0, was the most abundant group of 385 
FA (29.3-50.4%) in both cell types in all the species. Monounsaturated FA ranged 386 
between 13.7 and 28.9% of total FA, with about two-thirds being 18:1n-9. In enterocytes, 387 
total monounsaturated was slightly higher in P. lascaris (24.6% vs 13.7-16.3%). N-3 388 
PUFA were an important group of FA in this cell type, remaining fairly stable among 389 
species (23.7-26.7%). 20:4n-6 and 20:5n-3 were more abundant in S. salpa (~15%) than 390 
in P. lascaris and C. labrosus (ranging between 2.5 and 5.9%) whereas 22:6n-3 was more 391 
relevant in P. lascaris (16.0 ± 5.0%) and C. labrosus (18.4 ± 4.9%) than in S. salpa (2.8 392 
± 0.3%). Finally, 18:2n-6 represented between 3.5 and 7.7% of total FA in enterocytes 393 
from the three species. The FA composition of hepatocytes from S. salpa showed higher 394 
proportions of total n-3 PUFA, 20:5n-3, 22:5n-3 and 20:4n-6 than P. lascaris and C. 395 
labrosus while 22:6n-3 content was higher in hepatocytes from C. labrosus (12.3%) in 396 
comparison to S. salpa and P. lascaris (5.1% and 5.2%, respectively) (Table 3).  397 
Table 4 shows the incorporation of radioactivity into TL of enterocytes and 398 
hepatocytes of the three species. Overall, both [1-14C] C18 PUFA were generally the most 399 
incorporated FA in both cell types. Regardless of cell type and fish species, [1-14C] 22:6n-400 
3 tended to be the least incorporated FA. P. lascaris presented the highest values of 401 
incorporation for all radiolabeled substrates in enterocytes, and for [1-14C] 18:3n-3 in 402 
hepatocytes. FA incorporation seems to be higher in hepatocytes than in enterocytes of S. 403 
salpa. By contrast, P. lascaris presented the opposite trend although [1-14C] 22:6n-3 did 404 
not differ between isolated cells (Table 4). 405 
18 
 
3.2 Bioconversion of radiolabeled FAs 406 
Bioconversion of [1-14C] 18:2n-6, 18:3n-3 and 20:5n-3 in enterocytes and hepatocytes 407 
of the three fish species studied is shown in Table 5. Regardless of cellular type and 408 
species, the majority of radioactivity was consistently recovered as the unmodified 409 
substrate (59.1-92.3%). Nonetheless, enterocytes tended to show higher bioconversion 410 
rates (estimated as the sum of the products derived from each radiolabeled substrate) in 411 
both S. salpa (ranging from 10.6 to 37.0%) and C. labrosus (ranging from 10.3 to 37.6%) 412 
than in P. lascaris (ranging from 7.7 to 29.3%), with [1-14C] 20:5n-3 being the most 413 
modified FA (29.3-37.6%) in the three species (Table 5). Elongation was the most 414 
prominent activity over all substrates assayed in enterocytes from both S. salpa and P. 415 
lascaris and only over 20:5n-3 in C. labrosus. In addition, desaturation was registered 416 
exclusively towards [1-14C] 18:3n-3 in S. salpa and [1-14C] 18:2n-6 in P. lascaris (<1%). 417 
On the other hand, products obtained from the action of both elongases and desaturases 418 
(E+D, elongation/desaturation) over the radiolabeled PUFA notably varied among 419 
substrates and species in this cellular type. Thus, E+D products from [1-14C] 20:5n-3 were 420 
significantly more abundant than those from [1-14C] 18:3n-3 in S. salpa, whereas [1-14C] 421 
18:2n-6 was the most modified substrate in C. labrosus (Table 5). 422 
[1-14C] 20:5n-3 was also the most modified PUFA (22.5-40.9%) in hepatocytes except 423 
in C. labrosus, where [1-14C] 18:2n-6 was bio-converted to a similar extent (Table 5). 424 
Similarly to enterocytes, elongation was the most common activity over all substrates in 425 
hepatocytes from P. lascaris and S. salpa (8.1-32.1% and 8.7-17.4%, respectively), and 426 
additionally, over [1-14C] 20:5n-3 in C. labrosus (21.9 ± 3.4%). Desaturation was 427 
exclusively observed towards both [1-14C] C18 PUFA in S. salpa and towards [1-
14C] 428 
18:2n-6 in P. lascaris, being in all cases < 3%. Moreover, E+D activity varied from 1.9 429 
to 22.2% between substrates and species (Table 5). Thus, [1-14C] 18:2n-6 tended to be 430 
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the most elongated and desaturated FA in hepatocytes from all species although only at a 431 
significant rate in S. salpa. 432 
Desaturation over [1-14C] 18:3n-3 and [1-14C] 18:2n-6 in enterocytes from S. salpa 433 
and P. lascaris, respectively, led to the production of 18:4n-3 (0.3 ± 0.4%) and 18:3n-6 434 
(1.0 ± 0.7%), respectively (Table 6). Although transformation of [1-14C] 18:2n-6 to 20:4n-435 
6 was only present in C. labrosus (1.3 ± 0.4%), 22:5n-6 was detected in all species (Table 436 
6). With respect to the n-3 series, both 20:5n-3 and 22:6n-3 were obtained from [1-14C] 437 
18:3n-3 in P. lascaris (0.3 ± 0.2 and 0.5 ± 0.5%, respectively) and C. labrosus (0.8 ± 0.3 438 
and 1.2 ± 0.3%, respectively) but not in S. salpa. However, only P. lascaris was able to 439 
synthesize 22:6n-3 from [1-14C] 20:5n-3 (4.6 ± 5.9%) (Table 6).  440 
Furthermore, 20:4n-6 was produced from [1-14C] 18:2n-6 in hepatocytes from both S. 441 
salpa (0.4 ± 0.5%) and C. labrosus (9.9 ± 6.7%). In addition, [1-14C] 18:3n-3 was 442 
bioconverted in a similar pattern as described above for enterocytes. More specifically, 443 
both 20:5n-3 and 22:6n-3 were obtained from [1-14C] 18:3n-3 in P. lascaris (1.2 ± 0.4% 444 
and 0.4 ± 0.7%, respectively) and C. labrosus (0.8 ± 0.7 and 1.4 ± 1.2%, respectively), 445 
whereas only 22:6n-3 was detected in S. salpa (0.9 ± 0.3%). Besides, only P. lascaris 446 
synthesize 22:6n-3 from [1-14C] 20:5n-3 (Table 6). 447 
3.3 Elovl5 sequences, phylogenetics, functional characterization and tissue 448 
expression  449 
Elovl5 elongase from S. salpa, P. lascaris and C. labrosus consist of an ORF of 885, 450 
867 and 876 bp, encoding putative proteins of 295, 289 and 292 aa, respectively. The 451 
newly cloned elovl5 cDNA sequences were deposited in the GenBank database under the 452 
accession numbers MT019561, MT019562 and MT019563. Our phylogenetic analysis 453 
showed that the three elongases clustered together within a branch containing Elovl5 from 454 
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vertebrates, itself separated from other PUFA elongases, namely Elovl2 and Elovl4 (Fig. 455 
2). These results confirm that the sequences investigated herein are all Elovl5 elongases. 456 
The putative proteins encoded by the elovl5 cDNA sequences were functionally 457 
characterized in yeast. Our results show that the three Elovl5 had activity over all C18 and 458 
C20 PUFA substrates assayed (Table 7). With the exception of Elovl5 in P. lascaris which 459 
exhibited a remarkably low activity towards 22:5n-3, the herein functionally 460 
characterized Elovl5 did not have the capacity to elongate C22 PUFA substrates (Table 461 
7).  462 
The highest expression of elovl5 in both S. salpa and P. lascaris was observed in liver, 463 
gut and brain whereas in C. labrosus, brain presented the highest expression ratio, and 464 




4. Discussion 467 
The ability of fish to biosynthesize LC-PUFA is one of the factors to be considered to 468 
determine the potential interest of a particular species as candidate for the diversification 469 
of aquaculture. Thus, it could allow for both the development of feedstuff formulations 470 
optimized for the target species as well as the selection of fish with high capacity to utilize 471 
C18 fatty acid precursors from dietary VO while maintaining proper growth and 472 
development, and its nutritional quality in terms of flesh n-3 LC-PUFA content. 473 
In the present work, the incorporation of radioactivity into total lipids of isolated cells 474 
from the three fish species studied (S. salpa, P. lascaris and C. labrosus) showed notable 475 
differences between [1-14C] C18 PUFA precursors (18:2n-6 and 18:3n-3) and [1-
14C] LC-476 
PUFA (20:5n-3 and 22:6n-3). Overall, both enterocytes and hepatocytes seem to 477 
preferentially incorporate C18 precursors, followed by 20:5n-3 and finally 22:6n-3 (Table 478 
4), in spite of the reported physiological importance of these two LC-PUFA. A similar 479 
pattern was found in juvenile of S. aurata (Mourente and Tocher, 1993a). However, due 480 
to results obtained in a subsequent study in S. aurata, together with studies in L. aurata 481 
and Scophthalmus maximus (Linares and Henderson, 1991; Mourente and Tocher, 1993b, 482 
1994), a preferential retention of 20:5n-3 in marine fish was proposed (Mourente and 483 
Tocher, 1994). A lower affinity of proteins involved in FA membrane translocation 484 
processes for LC-PUFA and a poorer ability of ≥C20 PUFA to diffuse through cell 485 
membranes (Pérez et al., 1999) may be responsible for the observed incorporation 486 
differences. In addition, although β-oxidation measurement was not carried out in our 487 
study due to sample limitation, a preferential β-oxidation activity over C18 precursors 488 
could not be ruled out since C18 PUFA are readily oxidized substrates, in comparison with 489 
LC-PUFA, which are mostly preserved and stored in tissue membranes (Almaida-Pagán 490 
et al., 2007; Mourente et al., 2005). Thus, the apparent affinity for C18 PUFA in the 491 
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studied species may be due either, to the ability of cells to more easily incorporate FA 492 
with shorter chains (C18 vs. ≥C20-22) or to their preference to be β-oxidized. 493 
Regardless of the species, bioconversion rates in enterocytes and hepatocytes ranged 494 
between 7.7 and 40.9% (Table 5), showing higher bioconversion capacities than other 495 
teleosts previously studied such as S. aurata, S. maximus or S. senegalensis (Díaz-López 496 
et al., 2010; Morais et al., 2015; Rodrı́guez et al., 2002). Moreover, as it has been 497 
previously reported in S. maximus and S. senegalensis (Morais et al., 2015; Rodrı́guez et 498 
al., 2002), 20:5n-3 is the most modified FA, mainly elongated by Elovl5 action, in the 499 
enterocytes of the three species, and in the hepatocytes of S. salpa and P. lascaris. In spite 500 
of this, 22:6n-3 from [1-14C] 20:5n-3 was only detected in P. lascaris (Table 6), probably 501 
due to the 4 activity described before (Garrido et al., 2019), although the Sprecher route 502 
may not be completely ruled out in this species, as it will be further discussed in this work. 503 
Our recent previous results (Garrido et al., 2019) demonstrated the existence of a Fads2 504 
with 6 and 8 activities in S. salpa by heterologous expression in yeast. Therefore, the 505 
presence of 18:4n-3 and 24:6n-3 in both enterocytes and hepatocytes of S. salpa incubated 506 
with [1-14C] 18:3n-3 agrees well with the 6 activity above mentioned, although for 507 
incubations with [1-14C] 18:2n-6 this activity was found exclusively in hepatocytes (Table 508 
6). Also in agreement with our results on S. salpa, the Δ6 activity for Fads2 towards both 509 
18:3n-3 and 24:5n-3 has also been observed in S. aurata using radioactivity-based assays 510 
and yeast expression systems (Mourente and Tocher, 1993a; Oboh et al., 2017; Tocher 511 
and Ghioni, 1999). Moreover, as reported herein for S. salpa, 18:3n-6 but not 24:5n-6 512 
was detected in S. aurata in vivo assays or when fibroblasts were incubated with [1-14C] 513 
18:2n-6 (Mourente and Tocher, 1993a; Tocher and Ghioni, 1999). Our present results in 514 
S. salpa add more evidences to the possible conservation of the Δ6 desaturase capacity 515 
among members of the Sparidae family as previously reported in S. aurata. In addition, 516 
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the presence of 20:3n-6 and 20:4n-3 in hepatocytes (Table 6), confirms the 8 activity 517 
recently suggested by our results using molecular tools (Garrido et al., 2019). A 5 518 
desaturation activity was also detected in hepatocytes of S. salpa, obtaining 20:4n-6 from 519 
the incubation with [1-14C] 18:2n-6. Activities, which have been also reported in S. 520 
aurata, together with the presence of trace levels of 20:5n-3. Thus, it is possible that 521 
Fads2 had also some 6/5 activity in these sparids. Finally, 22:6n-3 was only detected 522 
in hepatocytes incubated with [1-14C] 18:3n-3 but not with [1-14C] 20:5n-3. The lower 523 
total incorporation of [1-14C] 20:5n-3 compared to [1-14C] 18:3n-3 in S. salpa, may 524 
explain these differences of bioconversion rates between substrates.  525 
S. salpa displayed elongation activity in both the radiolabeled assays and in the 526 
functional characterization of Elovl5 by heterologous expression in yeast, obtaining C20 527 
and C22 products from the C18 and C20 precursors, respectively (Table 6, 7). Elovl5 is 528 
known to mainly act over C18 and C20 substrates as indicated by heterologous expression 529 
in yeast (Monroig et al., 2012). Furthermore, elongation activity over C22 PUFA was also 530 
observed in our study when cells were incubated with [1-14C] 20:5n-3 according to what 531 
has been reported in S. aurata (Agaba et al., 2005). Collectively, our results indicate that 532 
both S. salpa and S. aurata have a rather similar capacity for LC-PUFA biosynthesis 533 
despite the remarkably different trophic level of these two sparid species. 534 
P. lascaris enterocytes and hepatocytes displayed similar lipid metabolic 535 
characteristics. C20, C22 and C24 FAs were detected as elongation products when both cell 536 
types were incubated in the presence of [1-14C] C18 and [1-
14C] C20 substrates, in 537 
accordance to the Elovl5 activities detected in yeast (Table 6, 7), and as reported by 538 
Morais et al. (2012) in its phylogenetically close S. senegalensis. At the same time, 539 
multiple products of desaturation were identified with our experimental design. On one 540 
hand, the presence of 22:5n-6 from [1-14C] 18:2n-6 as well as that of 22:6n-3 when 541 
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incubating with [1-14C] 18:3n-3 and [1-14C] 20:5n-3 (Fig. 1) in both cell types could 542 
confirm the 4 activity previously reported by our group with a molecular approach 543 
(Garrido et al., 2019). Nevertheless, these results seem to indicate that this species could 544 
have another Fads2 with 6/5 activity still uncharacterized. On the other hand, our 545 
radioactive assays suggest the existence of 6 and 8 activities when incubating with [1-546 
14C] 18:2n-6, based on the detection of 18:3n-6 and 20:3n-6, as well as 24:5n-6 in 547 
enterocytes (Table 6). While similar bioconversions were not registered when using [1-548 
14C] 18:3n-3 as substrate, the transformations towards [1-14C] 18:2n-6 indicate that P. 549 
lascaris may possess, along with the 4 Fads2 previously alluded (Garrido et al., 2019), 550 
a second Fads2 with 6/8 activities, and a possible residual 6/5 activity as Morais et 551 
al. (2015) suggested in S. senegalensis. What is more, perhaps a n-6 preference/specificity 552 
could be the reason why Morais et al. (2015) did not find 6 activity in S. senegalensis, 553 
since only [1-14C] 18:3n-3 and [1-14C] 20:5n-3 were used as substrates. Importantly, these 554 
results suggest that P. lascaris seems to be able to biosynthesize 22:6n-3 via two different 555 
routes, namely the 4 pathway operated by the functionally characterized Fads2 (Garrido 556 
et al., 2019), and the Sprecher pathway operated by a yet uncharacterized Fads2.  557 
The enzymatic activity assays carried out on C. labrosus enterocytes and hepatocytes 558 
demonstrated that this species has 8 and 5 desaturase capacities, as well as the ability 559 
to biosynthesize 22:6n-3 from [1-14C] 18:3n-3 (Table 6). Although the 8 desaturase 560 
activity was demonstrated in the 6/8 Fads2 characterized in our earlier study on C. 561 
labrosus (Garrido et al., 2019), no activity as 5 desaturase was detected through 562 
molecular tools for that enzyme. Therefore, the present study performed in isolated cells 563 
suggest that C. labrosus has extra copies of Fads2, possibly containing 5 desaturation 564 
capacity. Consequently, the coexistence of 5, 6 and 8 activities within C. labrosus 565 
may account for all the desaturation reactions required for the bioconversion of 18:3n-3 566 
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to 22:6n-3 detected in our experiments. 22:6n-3 biosynthesis seemed to be performed by 567 
the Sprecher pathway as it has been previously described for L. aurata (Mourente and 568 
Tocher, 1993b). However, as C24 intermediaries of the Sprecher pathway were not 569 
detected in the enzymatic assays (Table 6), the Δ4 pathway cannot be completely ruled 570 
out. Fads2 with Δ4 activity has not been yet characterized in the Mugilidae family, but it 571 
has been demonstrated in other families from the same lineage Ovalentaria, such as 572 
Cichlidae or Atherinidae (Fonseca-Madrigal et al., 2014; Garrido et al., 2019; Oboh et 573 
al., 2017). 22:6n-3 is biosynthesized from [1-14C] 18:3n-3 but not from [1-14C] 20:5n-3 574 
in C. labrosus. In S. salar, the addition of 20:5n-3 inhibited LC-PUFA biosynthesis in 575 
cells lines (AS) (Zheng et al., 2009b), while increasing doses of 20:5n-3 decreased the Δ5 576 
and Δ6 gene expression in the same species Kjær et al. (2016). This, together with the 577 
lower incorporation into total lipid of [1-14C] 20:5n-3 vs. [1-14C] 18:3n-3, could account 578 
for the differences found between both substrates (Table 4). 579 
Both the functional characterization of Elovl5 in yeast and radiolabeled assays with 580 
isolated cells showed elongation from C18 and C20 precursors to C20 and C22 products 581 
(Table 6, 7), respectively, in C. labrosus. The detection of 24:5n-3 when both cell types 582 
were incubated with [1-14C] 20:5n-3 could indicate the action of other Elovl, such as 583 
Elovl4, which is able to elongate a range of PUFA substrates including 22:5n-3 (Monroig 584 
et al., 2011b, 2012). 585 
The gene expression pattern of elovl5 varied among species. S. salpa and P. lascaris 586 
had the highest number of transcripts in the liver, gut and brain, while this occurred in the 587 
brain of C. labrosus, where liver and gill showed the lowest expression (Fig. 3). Until 588 
now, the differences in tissue gene expression distribution have been hypothesized to be 589 
associated to the origin of the species (marine or freshwater) (Kabeya et al., 2017). 590 
Furthermore, it is known that different factors such as nutritional history, developmental 591 
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stage, etc., can affect the tissue distribution patterns of elovl5 (Monroig et al., 2018). 592 
Besides gut and liver, a few evidences suggest that other tissues can also biosynthesize 593 
LC-PUFA. In this sense, the brain is a conservative tissue rich in LC-PUFA and therefore, 594 
a higher number of transcripts could be necessary in order to satisfy an optimal level of 595 
LC-PUFA for proper function (Zheng et al., 2009a).   596 
It has been hypothesized that fish occupying low trophic levels, require only C18 PUFA 597 
in the diet, being capable of de novo biosynthesize LC-PUFA, while those with high 598 
trophic levels, are unable to form LC-PUFA from C18 precursors and therefore need a 599 
dietary supply of LC-PUFA. Nonetheless, fish occupying intermediate trophic level, 600 
which may require either C18 PUFA or LC-PUFA depending on their ecological niche 601 
and life history, called into question this generalization (Trushenski and Rombenso, 602 
2019). Our results obtained in three fish species with different trophic level, indicate that 603 
this factor might not be a good indicator for LC-PUFA biosynthesis. 604 
In conclusion, phylogeny of the fish species, instead of trophic level, might be a more 605 
relevant factor in the LC-PUFA biosynthetic capacity. S. salpa and P. lascaris showed 606 
lipid metabolism characteristics similar to two established commercial species such as S. 607 
aurata and S. senegalensis, respectively, and could be adequate candidates for 608 
aquaculture diversification. The LC-PUFA biosynthetic capacity of wild S. salpa, P. 609 
lascaris and C. labrosus resembled that of their phylogenetically close species S. aurata, 610 
S. senegalensis and L. aurata, respectively. The desaturase activities observed in this 611 
study include 5, 6 and 8 activities in S. salpa, 5 and 8 activity in C. labrosus, and 612 
6/5 residual activity and 4 in P. lascaris. Thus, confirming the ability of the three 613 





This study was funded by Ministerio de Economía y Competitividad (AGL2015-617 
70994-R). A. Galindo and M. Marrero are supported by a PhD grant by Cajasiete and 618 
Gobierno de Canarias, respectively. Dr. Covadonga Rodríguez and Dr. Ana Bolaños are 619 
members of the Instituto de Tecnologías Biomédicas de Canarias (ITB). We also thank 620 
Dr. Inmaculada Giráldez from Universidad de Huelva for her assistance with laboratory 621 
facilities and Dr. Deiene Rodríguez-Barreto for her useful revision and assistance with 622 





Agaba, M.K., Tocher, D.R., Zheng, X., Dickson, C.A., Dick, J.R., Teale, A.J., 2005. 625 
Cloning and functional characterisation of polyunsaturated fatty acid elongases of 626 
marine and freshwater teleost fish. Comp. Biochem. Physiol. Part B Biochem. Mol. 627 
Biol. 142, 342-352. 628 
Almaida-Pagán, P.F., Hernández, M.D., García García, B., Madrid, J.A., De Costa, J., 629 
Mendiola, P., 2007. Effects of total replacement of fish oil by vegetable oils on n-3 630 
and n-6 polyunsaturated fatty acid desaturation and elongation in sharpsnout 631 
seabream (Diplodus puntazzo) hepatocytes and enterocytes. Aquaculture 272, 589-632 
598. 633 
Bell, M. V, Tocher, D.R., 2009. Biosynthesis of polyunsaturated fatty acids in aquatic 634 
ecosystems: general pathways and new directions, in: Kainz, M., Brett, M.T., Arts, 635 
M.T. (Eds.), Lipids in Aquatic Ecosystems. Springer New York, New York, NY, pp. 636 
211-236. 637 
Capella-Gutiérrez, S., Silla-Martínez, J.M., Gabaldón, T., 2009. trimAl: a tool for 638 
automated alignment trimming in large-scale phylogenetic analyses. Bioinformatics 639 
25, 1972-1973. 640 
Castro, L.F.C., Tocher, D.R., Monroig, Ó., 2016. Long-chain polyunsaturated fatty acid 641 
biosynthesis in chordates: Insights into the evolution of Fads and Elovl gene 642 
repertoire. Prog. Lipid Res. 62, 25-40. 643 
Christie, W.W., Han, X., 2010. Lipid analysis: isolation, separation, identification and 644 
lipidomic analysis. Oily Press, an imprint of PJ Barnes & Associates, pp. 55-66. 645 
Darriba, D., Posada, D., Kozlov, A.M., Stamatakis, A., Morel, B., Flouri, T., 2020. 646 
ModelTest-NG: a new and scalable tool for the selection of DNA and protein 647 
29 
 
evolutionary models. Mol. Biol. Evol. 37, 291-294. 648 
Díaz-López, M., Pérez, M.J., Acosta, N.G., Jerez, S., Dorta-Guerra, R., Tocher, D.R., 649 
Lorenzo, A., Rodríguez, C., 2010. Effects of dietary fish oil substitution by Echium 650 
oil on enterocyte and hepatocyte lipid metabolism of gilthead seabream (Sparus 651 
aurata L.). Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 155, 371-379.  652 
FAO, 2018. The state of world fisheries and aquaculture 2018: Meeting the sustainable 653 
development goals. Rome. Licence: CC BY-NC-SA 3.0 IGO. 654 
Folch, J., Lees, M., Sloane-Stanley, G.H., 1957. A Simple method for the isolation and 655 
purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509. 656 
Fonseca-Madrigal, J., Navarro, J.C., Hontoria, F., Tocher, D.R., Martínez-Palacios, C.A., 657 
Monroig, Ó., 2014. Diversification of substrate specificities in teleostei Fads2: 658 
characterization of Δ4 and Δ6Δ5 desaturases of Chirostoma estor. J. Lipid Res. 55, 659 
1408-1419. 660 
Garlito, B., Portoles, T., Niessen, W.M.A., Navarro, J.C., Hontoria, F., Monroig. Ó., 661 
Varó, I., Serrano, R., 2019. Identification of very long-chain (>C24) fatty acid 662 
methyl esters using gas chromatography coupled to quadrupole/time-of-flight mass 663 
spectrometry with atmospheric pressure chemical ionization source. Anal. Chim. 664 
Acta 1051, 103-109. 665 
Garrido, D., Kabeya, N., Betancor, M.B., Pérez, J.A., Acosta, N.G., Tocher, D.R., 666 
Rodríguez, C., Monroig, Ó., 2019. Functional diversification of teleost Fads2 fatty 667 
acyl desaturases occurs independently of the trophic level. Sci. Rep. 9, 11199. 668 
Garrido, D., Monroig, O., Galindo, A., Betancor, M. B., Perez, J. A., Kabeya, N., Marrero, 669 
M., Rodríguez, C. 2020. Lipid metabolism in Tinca tinca and its n-3 LC-PUFA 670 
biosynthesis capacity. Aquaculture, 523, 735147. 671 
30 
 
 Hastings, N., Agaba, M., Tocher, D.R., Leaver, M.J., Dick, J.R., Sargent, J.R., Teale, 672 
A.J., 2001. A vertebrate fatty acid desaturase with Delta 5 and Delta 6 activities. 673 
Proc. Natl. Acad. Sci. U. S. A. 98, 14304-14309. 674 
Kabeya, N., Chiba, M., Haga, Y., Satoh, S., Yoshizaki, G. 2017. Cloning and functional 675 
characterization of fads2 desaturase and elovl5 elongase from Japanese flounder 676 
Paralichthys olivaceus. Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 214, 677 
36-46. 678 
Kabeya, N., Yevzelman, S., Oboh, A., Tocher, D.R., Monroig, Ó., 2018. Essential fatty 679 
acid metabolism and requirements of the cleaner fish, ballan wrasse Labrus bergylta: 680 
Defining pathways of long-chain polyunsaturated fatty acid biosynthesis. 681 
Aquaculture 488, 199-206. 682 
Katoh, K., Rozewicki, J., Yamada, K.D., 2019. MAFFT online service: multiple sequence 683 
alignment, interactive sequence choice and visualization. Brief. Bioinform. 20, 684 
1160-1166. 685 
Kjær, M.A., Ruyter, B., Berge, G.M., Sun, Y., Østbye, T.-K.K., 2016. Regulation of the 686 
omega-3 fatty acid biosynthetic pathway in Atlantic salmon hepatocytes. PLoS One 687 
11, e0168230. 688 
Kuah, M.-K., Jaya-Ram, A., Shu-Chien, A.C., 2015. The capacity for long-chain 689 
polyunsaturated fatty acid synthesis in a carnivorous vertebrate: Functional 690 
characterisation and nutritional regulation of a Fads2 fatty acyl desaturase with Δ4 691 
activity and an Elovl5 elongase in striped snakehead (Channa striata). Biochim. 692 
Biophys. Acta - Mol. Cell Biol. Lipids 1851, 248-260. 693 
Lee, J., Lee, H., Kang, S., Park, W., 2016. Fatty acid desaturases, polyunsaturated fatty 694 
acid regulation, and biotechnological advances. Nutrients 8, 23. 695 
31 
 
Letunic, I., Bork, P., 2016. Interactive tree of life (iTOL) v3: an online tool for the display 696 
and annotation of phylogenetic and other trees. Nucleic Acids Res. 44, W242-W245. 697 
Li, Y., Monroig, Ó., Zhang, L., Wang, S., Zheng, X., Dick, J.R., You, C., Tocher, D.R., 698 
2010. Vertebrate fatty acyl desaturase with Δ4 activity. Proc. Natl. Acad. Sci. U. S. 699 
A. 107, 16840-16845. 700 
Linares, F., and Henderson, R. J. 1991. Incorporation of 14C‐labelled polyunsaturated 701 
fatty acids by juvenile turbot, Scophthalmus maximus (L.) in vivo. J. Fish Biol. 38, 702 
335-347. 703 
Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., 1951. Protein measurement 704 
with the Folin phenol reagent. J. Biol. Chem. 193, 265-275. 705 
Monroig, Ó., Li, Y., Tocher, D.R., 2011a. Delta-8 desaturation activity varies among fatty 706 
acyl desaturases of teleost fish: High activity in delta-6 desaturases of marine 707 
species. Comp. Biochem. Physiol. Part B Biochem. Mol. Biol. 159, 206-213. 708 
Monroig, Ó., Lopes-Marques, M., Navarro, J. C., Hontoria, F., Ruivo, R., Santos, M. 709 
M., Venkatesh, B., Tocher, D.R., Castro, L.F.C., 2016. Evolutionary functional 710 
elaboration of the Elovl2/5 gene family in chordates. Sci. Rep. 6, 1-10. 711 
Monroig, Ó., Tocher, D.R., Castro, L.F.C., 2018. Polyunsaturated fatty acid biosynthesis 712 
and metabolism in fish, in: Burdge, G. (Ed.), Polyunsaturated Fatty Acid 713 
Metabolism. AOCS Press, London, pp. 31-60. 714 
Monroig, Ó., Wang, S., Zhang, L., You, C., Tocher, D.R., Li, Y., 2012. Elongation of 715 
long-chain fatty acids in rabbitfish Siganus canaliculatus: Cloning, functional 716 
characterisation and tissue distribution of Elovl5- and Elovl4-like elongases. 717 
Aquaculture 350–353, 63-70. 718 
Monroig, Ó., Webb, K., Ibarra-Castro, L., Holt, G.J., Tocher, D.R., 2011b. Biosynthesis 719 
32 
 
of long-chain polyunsaturated fatty acids in marine fish: Characterization of an 720 
Elovl4-like elongase from cobia Rachycentron canadum and activation of the 721 
pathway during early life stages. Aquaculture 312, 145-153. 722 
Morais, S., Castanheira, F., Martinez-Rubio, L., Conceição, L.E.C., Tocher, D.R., 2012. 723 
Long chain polyunsaturated fatty acid synthesis in a marine vertebrate: Ontogenetic 724 
and nutritional regulation of a fatty acyl desaturase with Δ4 activity. Biochim. 725 
Biophys. Acta - Mol. Cell Biol. Lipids 1821, 660-671. 726 
Morais, S., Mourente, G., Martínez, A., Gras, N., Tocher, D.R., 2015. Docosahexaenoic 727 
acid biosynthesis via fatty acyl elongase and Δ4-desaturase and its modulation by 728 
dietary lipid level and fatty acid composition in a marine vertebrate. Biochim. 729 
Biophys. Acta - Mol. Cell Biol. Lipids 1851, 588-597. 730 
Mourente, G., Dick, J. R., Bell, J. G., Tocher, D. R. 2005. Effect of partial substitution of 731 
dietary fish oil by vegetable oils on desaturation and β-oxidation of [1-14C] 18: 3n-3 732 
(LNA) and [1-14C] 20: 5n-3 (EPA) in hepatocytes and enterocytes of European sea 733 
bass (Dicentrarchus labrax L.). Aquaculture 248, 173-186. 734 
Mourente, G., Tocher, D.R., 1993a. Incorporation and metabolism of 14C-labelled 735 
polyunsaturated fatty acids in juvenile gilthead sea bream Sparus aurata L. in vivo. 736 
Fish Physiol. Biochem. 10, 443-453. 737 
Mourente, G., Tocher, D.R., 1993b. Incorporation and metabolism of 14C-labelled 738 
polyunsaturated fatty acids in wild-caught juveniles of golden grey mullet, Liza 739 
aurata, in vivo. Fish Physiol. Biochem. 12, 119-130.  740 
Mourente, G., Tocher, D. R. 1994. In vivo metabolism of [1-14C] linolenic acid (18: 3 (n− 741 
3)) and [1-14C] eicosapentaenoic acid (20: 5 (n− 3)) in a marine fish: Time-course of 742 
the desaturation/elongation pathway. Biochim. Biophys. Acta, Lipids Lipid 743 
33 
 
Metab. 1212, 109-118. 744 
Oboh, A., Kabeya, N., Carmona-Antoñanzas, G., Castro, L.F.C., Dick, J.R., Tocher, D.R., 745 
Monroig, Ó., 2017. Two alternative pathways for docosahexaenoic acid (DHA, 746 
22:6n-3) biosynthesis are widespread among teleost fish. Sci. Rep. 7, 3889. 747 
Pérez, J. A., Rodríguez, C., Bolaños, A., Cejas, J.R., Lorenzo, A., 2014. Beef tallow as 748 
an alternative to fish oil in diets for gilthead sea bream (Sparus aurata) juveniles: 749 
Effects on fish performance, tissue fatty acid composition, health and flesh 750 
nutritional value. Eur. J. Lipid Sci. Technol. 116, 571-583. 751 
Pérez, J. A., Rodríguez, C., Henderson, R. J. 1999. The uptake and esterification of 752 
radiolabelled fatty acids by enterocytes isolated from rainbow trout (Oncorhynchus 753 
mykiss). Fish Physiol. Biochem. 20, 125-134. 754 
Rodríguez, C., Pérez, J.A., Henderson, R.J., 2002. The esterification and modification of 755 
n-3 and n-6 polyunsaturated fatty acids by hepatocytes and liver microsomes of 756 
turbot (Scophthalmus maximus). Comp. Biochem. Physiol. Part B Biochem. Mol. 757 
Biol. 132, 559-570. 758 
Ruyter, B., Sissener, N. H., Østbye, T. K., Simon, C. J., Krasnov, A., Bou, M., Sanden, 759 
M., Nichols, P. D., Lutfi, E., Berge, G. M. 2019. n-3 Canola oil effectively replaces 760 
fish oil as a new safe dietary source of DHA in feed for juvenile Atlantic 761 
salmon. British Journal of Nutrition, 122, 1329-1345. 762 
Sprague, M., Dick, J.R., Tocher, D.R., 2016. Impact of sustainable feeds on omega-3 763 
long-chain fatty acid levels in farmed Atlantic salmon, 2006–2015. Sci. Rep. 6, 764 
21892. 765 
Sprecher, H., 2000. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim. 766 
Biophys. Acta - Mol. Cell Biol. Lipids 1486, 219-231. 767 
34 
 
Tocher, D.R., 2015. Omega-3 long-chain polyunsaturated fatty acids and aquaculture in 768 
perspective. Aquaculture 449, 94-107. 769 
Tocher, D. R., Betancor, M. B., Sprague, M., Olsen, R. E., Napier, J. A. 2019. Omega-3 770 
long-chain polyunsaturated fatty acids, EPA and DHA: bridging the gap between 771 
supply and demand. Nutrients, 11, 89. 772 
Tocher, D.R., Ghioni, C., 1999. Fatty acid metabolism in marine fish: Low activity of 773 
fatty acyl Δ5 desaturation in gilthead sea bream (Sparus aurata) cells. Lipids 34, 774 
433-440. 775 
Trushenski, J. T., Rombenso, A. N., 2019. Trophic levels predict the nutritional 776 
essentiality of polyunsaturated fatty acids in fish-introduction to a special section 777 
and a brief synthesis. N Am J Aquacult, doi: 10.1 002/naaq.10137. 778 
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., 779 
Speleman, F., 2002. Accurate normalization of real-time quantitative RT-PCR data 780 
by geometric averaging of multiple internal control genes. Genome Biol. 3(7), 781 
research 0034. 782 
Wilson, R., Sargent, J.R., 1992. High-resolution separation of polyunsaturated fatty acids 783 
by argentation thin-layer chromatography. J. Chromatog. A, 623, 403-407. 784 
Zar, J.H., 1999. Biostatistical Analysis, 4th ed. Prentice-Hall Inc., Upper Saddle River. 785 
Zárate, R., el Jaber-Vazdekis, N., Tejera, N., Pérez, J.A., Rodríguez, C., 2017. 786 
Significance of long chain polyunsaturated fatty acids in human health. Clin. Transl. 787 
Med. 6, 25. 788 
Zheng, X., Ding, Z., Xu, Y., Monroig, Ó., Morais, S., Tocher, D. R. 2009a. Physiological 789 
roles of fatty acyl desaturases and elongases in marine fish: characterisation of 790 
cDNAs of fatty acyl Δ6 desaturase and elovl5 elongase of cobia (Rachycentron 791 
35 
 
canadum). Aquaculture, 290, 122-131. 792 
Zheng, X., Leaver, M.J., Tocher, D.R., 2009b. Long-chain polyunsaturated fatty acid 793 
synthesis in fish: Comparative analysis of Atlantic salmon (Salmo salar L.) and 794 
Atlantic cod (Gadus morhua L.) Δ6 fatty acyl desaturase gene promoters. Comp. 795 
Biochem. Physiol. Part B Biochem. Mol. Biol. 154, 255-263. 796 
36 
 
Table 1. Sequences of primer pairs used in the cloning of Sarpa salpa, Pegusa lascaris, and Chelon labrosus fatty acyl elongase (elovl5) open 797 
reading frame (ORF) and for quantitative real-time PCR (qPCR) analysis of gene expression in tissues. Restriction sites BamHI/XhoI for S. salpa 798 
(SSElovl5VF/SSElovl5VR), P. lascaris (PLElovl5VF/PLElovl5VR) and C. labrosus (CLElovl5VF/CLElovl5VR) are underlined in the 799 
corresponding primer sequences. 800 
Aim Species Transcript Primers Primers sequence 
First 
Fragment 
S. salpa elovl5 FFElovl5F1 5’- TACCCDCCAACCTTTGCACT -3’ 
  FFElovl5R1 5’- TCAATCCACCCTCAGCTTCTTG -3’ 
P. lascaris  FFElovl5F1 5’- TACCCDCCAACCTTTGCACT -3’ 
  FFElovl5R2 5’- TCAATCCACCCTYAGYTTCTTG -3’ 
C. labrosus  FFElovl5F1 5’- TACCCDCCAACCTTTGCACT -3’ 
  FFElovl5R2 5’- TCAATCCACCCTYAGYTTCTTG -3’ 
RACE PCR S. salpa elovl5 3’SSElovl5F1 5’- CCGTACCTTTGGTGGAAGAAGT -3’ 
   3’SSElovl5F2 5’- CAGTTCCAGCTGATCCAGTTCT -3’ 
   5’SSElovl5R1 5’- TTCATGTACTTGGGCCCCATC -3’ 
   5’SSElovl5R2 5’- GGTGGGTAGTTGTCGAGCAG -3’ 
 P. lascaris  3’PLElovl5F1 5’- CCCCATGCGATGGCTATACTT -3’ 
   3’PLElovl5F2 5’- ACGTACAAGAAGCGCAGTGT -3’ 
   5’PLElovl5R1 5’- GTAGAAGTTGTAGCCCCCGTG -3’ 
   5’PLElovl5R2 5’- TGTAGAGCACCAGAAGGCCT -3’ 
 C. labrosus  3’CLElovl5F1 5’- ACATGTTCACACTCACCATCCT -3’ 
   3’CLElovl5F2 5’- TCAGACTTACAAAAAGCGCAGC -3’ 
   5’CLElovl5R1 5’- CTTCCTCTGCGCTGTGAGTG -3’ 
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   5’CLElovl5R2 5’- TTGTAGCCACCATGCCACAC -3’ 
ORF cloning S. salpa elovl5 SSElovl5UF 5’-CTCTCCCCTCCTCGAAAAGGTG -3’ 
   SSElovl5UR 5’-GAGAATGGGGTGACGGTTTCTCAAATG-3’ 
   SSElovl5VF 5’-CCCGGATCCAAAATGGAGACCTTC-3’ 
   SSElovl5VR 5’-CCGCTCGAGTCAATCCACTCTCAG-3’ 
 P. lascaris elovl5 PLElovl5UF 5’-GTGTGTGTAATCGCTGATCTTCATGG-3’ 
   PLElovl5UR 5’-GATGTTGGGTGATACTTCCTCAAAGG-3’ 
   PLElovl5VF 5’-CCCGGATCCAAAATGGAGACCTTC-3’ 
   PLElovl5VR 5’-CCGCTCGAGTCAATCCACCCTTAG-3’ 
 C. labrosus elovl5 CLElovl5UF 5’-GGCTGGGCGACTTGATGGTG-3’ 
   CLElovl5UR 5’-CCTCCTAGCAGCATTAGCTAACAC-3’ 
   CLElovl5VF 5’-CCCGGATCCAAAATGGAGGCCTTC-3’ 
   CLElovl5VR 5’- CCGCTCGAGTCAATCCACCCTC-3’ 
qPCR S. salpa elovl5 SSElovl5qF1 5’-ACAAGCACAGTGCGTCTCTAA-3’ 
   SSElovl5qR1 5’-ACGCACTACAGTGAGAATGGG-3’ 
 P. lascaris  PLElovl5qF1 5’-GCTGACAAAACCTGGAGAGC-3’ 
   PLElovl5qR1 5’-CCTCCTGGATGTCTTTTGGA-3’ 
 C. labrosus  CLElovl5qF1 5’-AGAACGGCTCCTCCCTATCA-3’ 
   CLElovl5qR1 5’-CAGCATTAGCTAACACGCTACA-3’ 
 S. salpa β-actin β-actinqF1 5’-CAGGGAGAAGATGACCCAGA-3’ 
   β-actinqR1 5’-ACAGTGCCCATCTATGAGGG-3’ 
 P. lascaris  β-actinqF1 5’-CAGGGAGAAGATGACCCAGA-3’ 
   β-actinqR1 5’-ACAGTGCCCATCTATGAGGG-3’ 
 C. labrosus  β-actinqF1 5’-CAGGGAGAAGATGACCCAGA-3’ 
   β-actinqR2 5’-CCCTCGTAGATGGGCACTGT-3’ 
 S. salpa elf1α efl1αqF1 5’-ATGCACCACGAGTCTCTGAC-3’ 




 P. lascaris  efl1αqF2 5’-GTGGAGATGCACCACGAGTC-3’ 
   efl1αqR1 5’-GGGTGGTTCAGGATGATGAC-3’ 
 C. labrosus  efl1αqF3 5’-GTCGAGATGCACCACGAGTC-3’ 
   efl1αqR1 5’-GGGTGGTTCAGGATGATGAC-3’ 
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Table 2. Reaction conditions for cloning, functional characterization and gene expression of elovl5 in Sarpa salpa, Pegusa lascaris and Chelon 801 
labrosus. 802 


















First Fragment S. salpa elovl5 FFElovl5F1 FFElovl5R1 95 (30) 56 (45) 72 (60) 35 
 P. lascaris  FFElovl5F1 FFElovl5R2 “ “ “ “ 
 C. labrosus  FFElovl5F1 FFElovl5R2 “  “  “ “ 
RACE PCR S. salpa elovl5 5' RACE Outer 5’SSElovl5R1 95 (30) 57 (30) 72 (90) 35 
   5' RACE Inner 5’SSElovl5R2 “ “ “ “ 
   3’SSElovl5F1 3' RACE Outer “ “ “ “ 
   3’SSElovl5F2 3' RACE Inner “ “ “ “ 
 P. lascaris  5' RACE Outer 5’PLElovl5R1 95 (30) 57 (30) 72 (90) 35 
   5' RACE Inner 5’PLElovl5R2 “ “ “ “ 
   3’PLElovl5F1 3' RACE Outer “ “ “ “ 
   3’PLElovl5F2 3' RACE Inner “ “ “ “ 
 C. labrosus  5' RACE Outer 5’CLElovl5R1 “ “ “ “ 




   3’CLElovl5F1 3' RACE Outer “ “ “ “ 
   3’CLElovl5F2 3' RACE Inner “ 59 (30) “ “ 
ORF cloning S. salpa elovl5 SSElovl5UF SSElovl5UR 95 (20) 55 (20) 72 (105) 40 
   SSElovl5VF SSElovl5VR “ “ “ “ 
 P. lascaris elovl5 PLElovl5UF PLElovl5UR 95 (20) 55 (20) 72 (105) 35 
   PLElovl5VF PLElovl5VR “ “ “ “ 
 C. labrosus elovl5 CLElovl5UF CLElovl5UR 95 (20) 55 (20) 72 (105) 40 
   CLElovl5VF CLElovl5VR “ “ “ “ 
qPCR S. salpa elovl5 SSElovl5qF1 SSElovl5qR1 95 (15) 58.5 (30) 72 (30) 35 
 P. lascaris  PLElovl5qF1 PLElovl5qR1 “ “ “ “ 
 C. labrosus  CLElovl5qF1 CLElovl5qR1 “ “ “ “ 
 S. salpa β-actin β-actinqF1 β-actinqR1 “ “ “ “ 
 P. lascaris  β-actinqF1 β-actinqR1 “ “ “ “ 
 C. labrosus  β-actinqF1 β-actinqR2 “ “ “ “ 
 S. salpa elf1α efl1αqF1 efl1αqR1 “ “ “ “ 
 P. lascaris  efl1αqF2 efl1αqR1 “ “ “ “ 
 C. labrosus  efl1αqF3 efl1αqR1 “ “ “ “ 
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Table 3. Total lipid (mg lipid/mg protein) and main fatty acid composition (% of total FA) of control enterocytes and hepatocytes from Sarpa 803 
salpa, Pegusa lascaris and Chelon labrosus. 804 
 Sarpa salpa  Pegusa lascaris  Chelon labrosus 
 Enterocytes Hepatocytes  Enterocytes Hepatocytes  Enterocytes Hepatocytes 
Total lipid 0.9 ± 0.2 3.0 ± 1.5  1.2 ± 0.0 1.8 ± 0.6  0.8 ± 0.2 2.2 ± 0.5 
Total saturated1 29.3 ± 1.8 35.5 ± 1.3  37.3 ± 1.6 50.4 ± 8.2  36.7 ± 6.0 44.2 ± 2.0 
14:0 0.8 ± 0.1 1.0 ± 0.1  1.4 ± 0.3 2.8 ± 1.1  1.4 ± 0.7 1.8 ± 0.3 
16:0 17.0 ± 0.8 22.5 ± 1.6  19.0 ± 0.5 31.3 ± 6.8  16.1 ± 8.5 23.0 ± 2.6 
18:0 11.4 ± 0.2 10.0 ± 1.0  13.9 ± 2.2 13.5 ± 2.8  14.3 ± 1.9 10.8 ± 0.9 
Total monoenes1 13.7 ± 0.5 19.6 ± 4.9  24.6 ± 5.6 28.9 ± 9.8  16.3 ± 2.8 23.4 ± 6.9 
16:12 1.9 ± 0.4 3.3 ± 2.5  2.6 ± 0.7 6.2 ± 2.0  2.0 ± 0.5 5.3 ± 3.8 
18:13 10.2 ± 0.9 15.3 ± 3.6  19.9 ± 4.3 19.1 ± 6.1  13.1 ± 1.9 16.5 ± 3.0 
20:13 0.7 ± 0.2 nd  0.2 ± 0.3 0.9 ± 0.4  0.7 ± 0.4 1.2 ± 0.9 
Total n-6 PUFA1 22.9 ± 0.6 15.1 ± 1.3  8.9 ± 0.4 6.6 ± 2.0  16.3 ± 3.3 10.0 ± 3.6 
18:2 3.5 ± 1.2 3.7 ± 0.7  4.0 ± 0.9 4.9 ± 3.0  7.7 ± 3.5 6.8 ± 2.1 
18:3 nd 0.1 ± 0.2  nd nd  nd nd 




14.9 ± 0.3 8.9 ± 1.6  2.5 ± 1.0 1.4 ± 0.6  5.9 ±1.9 2.7 ± 1.4 
22:5 0.7 ± 0.1 0.6 ± 0.1  1.2 ± 0.2 0.1 ± 0.2  1.2 ± 0.2 0.5 ± 0.1 
Total n-3 PUFA1 25.2 ± 2.5 23.0 ± 4.1  23.7 ± 6.3 9.7 ± 4.9  26.7 ± 5.7 16.8 ± 6.1 
18:3 0.9 ± 0.2 1.0 ± 0.2  0.6 ± 0.0 0.6 ± 0.0  1.2 ± 0.4 1.2 ± 0.2 
20:5 15.1 ± 1.6 10.3 ± 2.4  3.4 ± 0.2 2.1 ± 1.2  4.6 ± 1.1 2.5 ± 1.1 
22:5 5.8 ± 0.5 5.2 ± 1.4  3.5 ± 1.2 1.7 ± 1.1  1.9 ± 0.5 0.7 ± 0.3 
22:6 2.8 ± 0.3 5.1 ± 1.5  16.0 ± 5.0 5.2 ± 2.6  18.4 ± 4.9 12.3 ± 4.8 
n-3/n-6 1.1 ± 0.1 1.5 ± 0.2  2.7 ± 0.6 1.7 ± 1.2  1.7 ± 0.6 1.7 ± 0.2 
20:4n-6/20:5n-3 1.0 ± 0.1 0.9 ± 0.2  0.7 ± 0.3 0.7 ± 0.2  1.3 ± 0.3 1.0 ± 0.2 
22:6n-3/20:5n-3 0.2 ± 0.0 0.5 ± 0.2  4.7 ± 1.7 2.7 ± 0.4  4.1 ± 1.0 5.1 ± 1.2 
Total n-3 LC-PUFA1 24.3 ± 2.6 21.5 ± 4.4  23.0 ± 6.0 9.0 ± 4.8  26.7 ± 5.7 15.6 ± 6.1 
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Results are presented as mean ± SD (S. salpa, n=5; P. lascaris, n=3; C. labrosus, n= 6). LC-PUFA, long chain polyunsaturated fatty acids (≥ C20 805 




 Table 4. Incorporation of radioactivity into total lipids (pmol mg prot−1 h−1) of isolated enterocytes and hepatocytes of Sarpa salpa, Pegusa 807 
lascaris and Chelon labrosus incubated with [1-14C] 18:2n-6, [1-14C] 18:3n-3, [1-14C] 20:5n-3 and [1-14C] 22:6n-3. 808 
Values are presented as mean ± SD (S. salpa, n=5, except for [1-14C] 22:6n-3, where n=4; P. lascaris, n=3; C. labrosus, n= 6). Different letters in 809 
superscript denote significant differences between [1-14C] FA for each cell type (p<0.05).810 
 ENTEROCYTES  HEPATOCYTES  
[1-14C] FA 18:2n-6  18:3n-3  20:5n-3  22:6n-3  18:2n-6  18:3n-3  20:5n-3  22:6n-3  
Species                 
Sarpa salpa 90.5 ± 26.7 c 75.6 ± 26.0 bc 38.6 ± 19.7 ab 25.2 ± 10.7 a 154.7 ± 49.3  100.4 ± 37.9  71.2 ± 40.1  85.0 ± 49.5  
Pegusa lascaris 471.4 ± 50.9 c 211.9 ± 7.3 b 127.6 ± 45.6 b 59.7 ± 19.8 a 142.2 ± 18.4 b 173.0 ± 12.5 b 54.3 ± 31.5 a 58.2 ± 4.9 a 
Chelon labrosus 67.0 ± 16.3 b 67.5 ± 19.8 b 32.7 ± 13.8 a 12.3 ± 3.1 a 57.3 ± 35.3 b 88.5 ± 58.6 b 51.1 ± 25.4 b 10.7 ± 6.1 a 
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Table 5. Bioconversions (% of total radioactivity) registered in isolated enterocytes and 811 
hepatocytes from Sarpa salpa, Pegusa lascaris and Chelon labrosus incubated with [1-812 
14C] 18:2n-6, [1-14C] 18:3n-3 and [1-14C] 20:5n-3. 813 
Values are presented as mean ± SD (S. salpa, n=5; P. lascaris, n=3; C. labrosus, n= 6). 814 
E+D, elongation and desaturation; nd, not detected. De novo: shorter FAs produced by 815 
using the [1-14C] released after a first β-oxidation cycle of the radiolabeled substrate. 816 
Different letters in superscript denote significant differences between [1-14C] fatty acids 817 
for each cell type (p<0.05).  818 
 Sarpa salpa 
 ENTEROCYTES  HEPATOCYTES  
             
[1-14C] PUFA 18:2  18:3  20:5  18:2  18:3  20:5  
             
FA recovery 85.0 ± 5.0 b 89.4 ± 3.5 b 63.0 ± 2.8 a 80.8 ± 6.1 b 84.4 ± 2.0 b 68.0 ± 2.5 a 
Elongation 10.5 ± 5.3 a 8.1 ± 4.0 a 20.8 ± 3.3 b 8.7 ± 3.8 a 9.7 ± 3.5 a 17.4 ± 1.7 b 
Desaturation nd  0.3 ± 0.4  nd  1.7 ± 0.4  2.3 ± 1.0  nd  
E+D 2.4 ± 1.4 ab 0.5 ± 0.7 a 2.8 ± 1.2 b 7.0 ± 2.5 b 3.5 ± 1.8 a 1.9 ± 0.8 a 
De novo 1.9 ± 0.2 a 1.2 ± 0.6 a 12.8 ± 3.9 b 1.2 ± 0.2 a nd  10.0 ± 3.8 b 
Unknown 0.2 ± 0.2  0.5 ± 0.2  0.5 ± 1.1  0.6 ± 0.8  nd  2.6 ± 1.9  
             
 Pegusa lascaris 
 ENTEROCYTES  HEPATOCYES  
             
[1-14C] PUFA 18:2  18:3  20:5  18:2  18:3  20:5  
             
FA recovery 87.0 ± 1.8 b 92.3 ± 3.1 b 70.7 ± 5.1 a 80.6 ± 5.0 b 89.3 ± 3.2 b 59.1 ± 8.6 a 
Elongation 9.6 ± 0.9 a 6.8 ± 2.7 a 21.1 ± 1.0 b 13.3 ± 3.4 a 8.1 ± 4.2 a 32.1 ± 7.2 b 
Desaturation 1.0 ± 0.7  nd  nd  2.0 ± 0.7  nd  nd  
E+D 2.2 ± 0.6  0.8 ± 0.7  4.6 ± 5.9  3.5 ± 1.1 b 1.6 ± 0.5 a 2.7 ± 0.3 ab 
De novo nd  nd  3.6 ± 4.5  nd  1.0 ± 1.7  6.1 ± 3.7  
Unknown 0.2 ± 0.1  0.1 ± 0.2  nd  0.5 ± 1.0  nd  nd  
             
 Chelon labrosus 
 ENTEROCYTES  HEPATOCYTES  
             
[1-14C] PUFA 18:2  18:3  20:5  18:2  18:3  20:5  
             
FA recovery 83.9 ± 2.8 b 89.7 ± 0.6 c 62.4 ± 2.0 a 66.4 ±14.4 a 92.2 ± 1.6 b 77.5 ± 4.3 a 
Elongation 4.0 ± 1.0 a 4.5 ± 1.2 a 28.4 ± 1.2 b 9.5 ± 9.4 ab 2.0 ± 1.9 a 21.9 ± 3.4 b 
Desaturation nd  nd  nd  nd  nd  nd  
E+D 5.4 ± 0.9 b 3.5 ± 0.9 a nd  22.2 ±13.8  5.5 ± 1.6  nd  
De novo 5.6 ± 0.7 b nd  0.3 ± 0.4 a 1.8 ± 2.8  0.3 ± 0.6  nd  
Unknown 1.1 ± 1.2  2.3 ± 0.5  8.9 ± 2.2  nd  nd  0.6 ± 1.0  
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Table 6. Products obtained (% of total radioactivity) from the incubation of isolated 819 
enterocytes and hepatocytes with [1-14C] 18:2n-6, [1-14C] 18:3n-3 and [1-14C] 20:5n-3 820 
Values are presented as mean ± SD (S. salpa, n=5; P. lascaris, n=3; C. labrosus, n= 6). 821 
nd, not detected.  822 
 ENTEROCYTES  HEPATOCYTES 
 S. salpa P. lascaris C. labrosus  S. salpa P. lascaris C. labrosus 
        
[1-14C]18:2n-6       
18:3 nd 1.0 ± 0.7 nd  1.7 ± 0.4 2.0 ± 0.7 nd 
20:2 8.0 ± 5.2 8.3 ± 1.2 2.0 ± 0.5  7.2 ± 3.4 12.2 ± 0.8 4.4 ± 4.2 
20:3 nd 0.4 ± 0.3 nd  0.9 ± 0.9 0.3 ± 0.5 nd 
20:4 nd nd 1.3 ± 0.4  0.4 ± 0.5 nd 9.9 ± 6.7 
22:2 2.6 ± 0.8 1.3 ± 0.9 1.9 ± 0.6  1.5 ± 1.0 1.1 ± 1.9 5.1 ± 5.2 
22:4 1.2 ± 0.3 nd 0.8 ± 0.4  1.2 ± 1.2 nd nd 
22:5 1.3 ± 1.1 1.5 ± 1.0 3.3 ± 0.5  4.6 ±1.9 3.2 ± 1.1 12.3± 7.2 
24:5 nd 0.3 ± 0.6 nd  nd nd nd 
        
[1-14C]18:3n-3       
18:4 0.3 ± 0.4 nd nd  2.3 ± 1.0 nd nd 
20:3 7.2 ± 3.5 6.5 ± 2.9 1.5 ± 0.4  8.8 ± 4.0 8.1 ± 4.2 2.0 ± 1.9 
20:4 nd nd 1.5 ± 0.4  1.0 ± 0.3 nd 3.3 ± 3.2 
20:5 nd 0.3 ± 0.2 0.8 ± 0.3  nd 1.2 ± 0.4 0.8 ± 0.7 
22:3 1.0 ± 0.9 0.2 ± 0.4 0.9 ± 0.5  0.9 ± 0.9 nd nd 
22:5 nd nd 0.1 ± 0.2  0.4 ± 0.4 nd nd 
22:6 nd 0.5 ± 0.5 1.2 ± 0.3  0.9 ± 0.3 0.4 ± 0.7 1.4 ± 1.2 
24:3 nd nd 0.9 ± 0.5  nd nd nd 
24:6 0.5 ± 0.7 nd nd  1.2 ± 1.1 nd nd 
        
[1-14C]20:5n-3       
22:5 15.3 ± 2.6 12.7 ± 1.7 15.0 ± 0.3  14.6 ± 1.2 23.3 ± 4.4 12.4 ± 3.5 
22:6 nd 4.6 ± 5.9 nd  nd 2.7 ± 0.3 nd 
24:5 5.6 ± 2.1 8.4 ± 2.6 4.1 ± 0.7  2.8 ± 0.8 8.7 ± 4.3 4.9 ± 2.9 
24:6 2.8 ± 1.2 nd nd  1.9 ± 0.8 nd nd 
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Table 7. Percentage of conversion of fatty acid (FA) substrates exogenously added to 823 
transgenic yeast (Saccharomyces cerevisiae) transformed with the coding region of elovl5 824 
from Sarpa salpa, Pegusa lascaris and Chelon labrosus. 825 
  % conversion 
FA substrate FA product Sarpa salpa Pegusa lascaris Chelon labrosus 
18:2n-6 20:2n-6 5.1 29.6 15.2 
18:3n-3 20:3n-3 29.3 44.7 42.0 
18:3n-6 20:3n-6 38.3 81.6 58.4 
18:4n-3 20:4n-3 50.2 80.3 64.4 
20:4n-6 22:4n-6 30.2 36.1 27.0 
20:5n-3 22:5n-3 75.7 70.8 69.1 
22:4n-6 24:4n-6 nd nd nd 
22:5n-3 24:5n-3 nd 2.3 nd 
Results are expressed as a percentage of total fatty acid substrate converted to elongated 826 
product. nd, not detected.   827 
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Table SD (Supplementary data). Total lipid (% wet weight) and main fatty acid 828 
composition (% of total FA) of muscle from Sarpa salpa, Pegusa lascaris and Chelon 829 
labrosus. 830 
Results are presented as mean ± SD (S. salpa, n=5; P. lascaris, n=7; C. labrosus, n= 6). 831 
LC-PUFA, Long chain polyunsaturated fatty acids (≥ C20 and ≥ 2 double bonds); nd, not 832 
detected.1 Includes some minor components not shown; 2 Mainly n-7 isomer; 3 Mainly n-833 
9 isomer.  834 
 Sarpa salpa  Pegusa lascaris  Chelon labrosus 
Total lipid 0.5 ± 0.1  0.5 ± 0.1  0.9 ± 0.1 
Total saturated1 27.1 ± 0.7  28.8 ± 1.0  32.8 ± 2.2 
14:0 0.8 ± 0.1  1.0 ± 0.5  2.7 ± 0.6 
16:0 18.6 ± 0.5  18.2 ± 1.0  23.1 ± 1.7 
18:0 6.4 ± 0.3  7.4 ± 0.4  5.8 ± 1.0 
Total monoenes1 20.9 ± 2.4  17.9 ± 1.9  24.0 ± 3.2 
16:12 2.9 ± 0.5  2.7 ± 1.0  6.6 ± 1.1 
18:13 17.3 ± 2.1  13.6 ± 0.6  16.7 ± 2.5 
20:13 0.0 ± 0.1  0.6 ± 0.5  0.4 ± 0.1 
Total n-6 PUFA1 19.1 ± 0.6  8.2 ± 0.9  16.8 ± 1.1 
18:2 5.4 ± 1.7  1.4 ± 0.3  10.5 ± 1.9 
18:3 0.4 ± 0.0  nd  0.4 ± 0.1 




10.7 ± 1.0  4.3 ± 0.7  3.9 ± 0.7 
22:5 0.5 ± 0.2  1.3 ± 0.2  1.0 ± 0.3 
Total n-3 PUFA1 28.4 ± 2.3  41.4 ± 2.4  23.0 ± 3.3 
18:3 1.1 ± 0.2  0.4 ± 0.1  1.8 ± 0.5 
20:5 16.9 ± 1.7  6.0 ± 0.3  7.0 ± 1.2 
22:5 5.5 ± 0.6  5.9 ± 0.6  2.1 ± 0.4 
22:6 3.6 ± 0.4  28.7 ± 2.9  10.4 ± 3.1 
n-3/n-6 1.5 ± 0.2  5.1 ± 0.6  1.4 ± 0.2 
20:4n-6/20:5n-3 0.6 ± 0.0  0.7 ± 0.2  0.6 ± 0.1 
22:6n-3/20:5n-3 0.2 ± 0.0  4.8 ± 0.7  1.5 ± 0.6 
Total n-3 LC-PUFA1 26.8 ± 2.3  40.6 ± 2.4  20.0 ± 3.0 
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Figure legend 835 
Figure 1. Long-chain (C20-24) polyunsaturated fatty acids biosynthetic route from 836 
linoleic (n-6) and α-linolenic acid (n-3). 837 
Figure 2. Phylogenetic tree of elovl5 using the deduced amino acid sequences from Sarpa 838 
salpa, Pegusa lascaris and Chelon labrosus. The number over horizontal branch length 839 
shows the branch lengths which is proportional to the amino acid substitution rate per 840 
site, whereas the percentage number under the horizontal branch length is the bootstrap 841 
replicates from 1000 iterations. 842 
Figure 3. Tissue distribution of elovl5 in Sarpa salpa, Pegusa lascaris and Chelon 843 
labrosus. Data are presented as geometric mean log normalized expression ratios ± 844 
standard errors (S. salpa and P. lascaris n=4; C. labrosus, n=3). Different letters denote 845 
significant differences among tissue for each specie (p<0.05). 846 
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